292 related articles for article (PubMed ID: 27615271)
21. Cerebrospinal fluid interferon alpha levels correlate with neurocognitive impairment in ambulatory HIV-Infected individuals.
Anderson AM; Lennox JL; Mulligan MM; Loring DW; Zetterberg H; Blennow K; Kessing C; Koneru R; Easley K; Tyor WR
J Neurovirol; 2017 Feb; 23(1):106-112. PubMed ID: 27400930
[TBL] [Abstract][Full Text] [Related]
22. Dementia and neurocognitive disorders due to HIV-1 infection.
Ances BM; Ellis RJ
Semin Neurol; 2007 Feb; 27(1):86-92. PubMed ID: 17226745
[TBL] [Abstract][Full Text] [Related]
23. Peripheral immune dysregulation in the ART era of HIV-associated neurocognitive impairments: A systematic review.
Williams ME; Ipser JC; Stein DJ; Joska JA; Naudé PJW
Psychoneuroendocrinology; 2020 Aug; 118():104689. PubMed ID: 32479968
[TBL] [Abstract][Full Text] [Related]
24. Role of the immune system in HIV-associated neuroinflammation and neurocognitive implications.
Hong S; Banks WA
Brain Behav Immun; 2015 Mar; 45():1-12. PubMed ID: 25449672
[TBL] [Abstract][Full Text] [Related]
25. Coagulation imbalance and neurocognitive functioning in older HIV-positive adults on suppressive antiretroviral therapy.
Montoya JL; Iudicello J; Oppenheim HA; Fazeli PL; Potter M; Ma Q; Mills PJ; Ellis RJ; Grant I; Letendre SL; Moore DJ;
AIDS; 2017 Mar; 31(6):787-795. PubMed ID: 28099190
[TBL] [Abstract][Full Text] [Related]
26. Antiretroviral therapy improves cognitive impairment in HIV+ individuals in sub-Saharan Africa.
Sacktor N; Nakasujja N; Skolasky R; Robertson K; Wong M; Musisi S; Ronald A; Katabira E
Neurology; 2006 Jul; 67(2):311-4. PubMed ID: 16864825
[TBL] [Abstract][Full Text] [Related]
27. Cerebrospinal fluid metabolomics reveals altered waste clearance and accelerated aging in HIV patients with neurocognitive impairment.
Cassol E; Misra V; Dutta A; Morgello S; Gabuzda D
AIDS; 2014 Jul; 28(11):1579-91. PubMed ID: 24752083
[TBL] [Abstract][Full Text] [Related]
28. Plasma cytokine concentrations associated with HIV/hepatitis C coinfection are related to attention, executive and psychomotor functioning.
Cohen RA; de la Monte S; Gongvatana A; Ombao H; Gonzalez B; Devlin KN; Navia B; Tashima KT
J Neuroimmunol; 2011 Apr; 233(1-2):204-10. PubMed ID: 21146232
[TBL] [Abstract][Full Text] [Related]
29. Anemia and Red Blood Cell Indices Predict HIV-Associated Neurocognitive Impairment in the Highly Active Antiretroviral Therapy Era.
Kallianpur AR; Wang Q; Jia P; Hulgan T; Zhao Z; Letendre SL; Ellis RJ; Heaton RK; Franklin DR; Barnholtz-Sloan J; Collier AC; Marra CM; Clifford DB; Gelman BB; McArthur JC; Morgello S; Simpson DM; McCutchan JA; Grant I;
J Infect Dis; 2016 Apr; 213(7):1065-73. PubMed ID: 26690344
[TBL] [Abstract][Full Text] [Related]
30. HIV-associated neurocognitive disorders (HAND).
Elbirt D; Mahlab-Guri K; Bezalel-Rosenberg S; Gill H; Attali M; Asher I
Isr Med Assoc J; 2015 Jan; 17(1):54-9. PubMed ID: 25739180
[TBL] [Abstract][Full Text] [Related]
31. The effects of antiretroviral treatment initiation on cognition in HIV-infected individuals with advanced disease in Pune, India.
Ghate M; Mehendale S; Meyer R; Umlauf A; Deutsch R; Kamat R; Thakar M; Risbud A; Kulkarni S; Sakamoto M; Alexander T; Franklin D; Letendre S; Heaton RK; Grant I; Marcotte TD
J Neurovirol; 2015 Aug; 21(4):391-8. PubMed ID: 25750072
[TBL] [Abstract][Full Text] [Related]
32. White matter micro-structural changes in ART-naive and ART-treated children and adolescents infected with HIV in South Africa.
Hoare J; Fouche JP; Phillips N; Joska JA; Paul R; Donald KA; Thomas KG; Stein DJ
AIDS; 2015 Sep; 29(14):1793-801. PubMed ID: 26372385
[TBL] [Abstract][Full Text] [Related]
33. Does antiretroviral therapy improve HIV-associated cognitive impairment? A quantitative review of the literature.
Al-Khindi T; Zakzanis KK; van Gorp WG
J Int Neuropsychol Soc; 2011 Nov; 17(6):956-69. PubMed ID: 21813033
[TBL] [Abstract][Full Text] [Related]
34. Lifetime antiretroviral exposure and neurocognitive impairment in HIV.
Amusan P; Power C; Gill MJ; Gomez D; Johnson E; Rubin LH; Fujiwara E
J Neurovirol; 2020 Oct; 26(5):743-753. PubMed ID: 32720232
[TBL] [Abstract][Full Text] [Related]
35. Elevated Markers of Vascular Remodeling and Arterial Stiffness Are Associated With Neurocognitive Function in Older HIV+ Adults on Suppressive Antiretroviral Therapy.
Montoya JL; Iudicello J; Fazeli PL; Hong S; Potter M; Ellis RJ; Grant I; Letendre SL; Moore DJ;
J Acquir Immune Defic Syndr; 2017 Feb; 74(2):134-141. PubMed ID: 27828873
[TBL] [Abstract][Full Text] [Related]
36. [Antiretroviral agents in HIV-infected patients with cirrhosis].
Salmon-Céron D; Sogni P; Spiridon G; Taburet AM
Presse Med; 2005 Jun; 34(10 Suppl):1S45-52. PubMed ID: 16025667
[TBL] [Abstract][Full Text] [Related]
37. Cognitive impairment and antiretroviral treatment in a Peruvian population of patients with human immunodeficiency virus.
Guevara-Silva EA
Neurologia; 2014 May; 29(4):224-9. PubMed ID: 23972623
[TBL] [Abstract][Full Text] [Related]
38. [Neurocognitive impairments of HIV infected individuals -- preliminary results of a national prevalence study in Hungary].
Lakatos B; Szabó Z; Bozzai B; Bánhegyi D; Gazdag G
Ideggyogy Sz; 2014 Nov; 67(11-12):409-14. PubMed ID: 25720243
[TBL] [Abstract][Full Text] [Related]
39. HIV-associated neurocognitive disorders: antiretroviral regimen, central nervous system penetration effectiveness, and cognitive outcomes.
Cross HM; Combrinck MI; Joska JA
S Afr Med J; 2013 Sep; 103(10):758-62. PubMed ID: 24079630
[TBL] [Abstract][Full Text] [Related]
40. Neurocognitive functioning and HAART in HIV and hepatitis C virus co-infection.
Parsons TD; Tucker KA; Hall CD; Robertson WT; Eron JJ; Fried MW; Robertson KR
AIDS; 2006 Aug; 20(12):1591-5. PubMed ID: 16868439
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
